Jpmorgan Chase & CO Pliant Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 481,097 shares of PLRX stock, worth $712,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares
481,097
Previous 197,251 143.9%
Holding current value
$712,023
Previous $2.6 Million 75.01%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$1.35 - $13.53 $383,192 - $3.84 Million
283,846 Added 143.9%
481,097 $649,000
Q4 2024

Feb 12, 2025
BUY
$10.55 - $15.7 $1.56 Million - $2.32 Million
148,039 Added 300.82%
197,251 $2.6 Million
Q3 2024

Dec 26, 2024
BUY
$10.52 - $14.35 $231 - $315
22 Added 0.04%
49,212 $551,000
Q3 2024

Nov 08, 2024
BUY
$10.52 - $14.35 $231 - $315
22 Added 0.04%
49,212 $551,000
Q2 2024

Dec 26, 2024
SELL
$10.58 - $15.61 $232 - $343
-22 Reduced 0.04%
49,190 $528,000
Q2 2024

Aug 12, 2024
SELL
$10.58 - $15.61 $96,680 - $142,644
-9,138 Reduced 15.67%
49,190 $528,000
Q1 2024

Dec 26, 2024
BUY
$14.14 - $19.59 $128,900 - $178,582
9,116 Added 18.52%
58,328 $869,000
Q1 2024

May 10, 2024
SELL
$14.14 - $19.59 $385,527 - $534,121
-27,265 Reduced 31.85%
58,328 $869,000
Q4 2023

Dec 26, 2024
BUY
$12.85 - $19.15 $467,495 - $696,696
36,381 Added 73.93%
85,593 $1.55 Million
Q4 2023

Feb 12, 2024
BUY
$12.85 - $19.15 $48,148 - $71,755
3,747 Added 4.58%
85,593 $1.55 Million
Q3 2023

Nov 14, 2023
BUY
$14.58 - $20.15 $126,102 - $174,277
8,649 Added 11.82%
81,846 $1.42 Million
Q2 2023

Aug 11, 2023
BUY
$18.12 - $30.56 $941,696 - $1.59 Million
51,970 Added 244.83%
73,197 $1.33 Million
Q1 2023

May 18, 2023
BUY
$18.73 - $36.26 $387,486 - $750,146
20,688 Added 3838.22%
21,227 $564,000
Q1 2023

May 11, 2023
SELL
$18.73 - $36.26 $270,086 - $522,869
-14,420 Reduced 96.4%
539 $14,000
Q4 2022

Feb 13, 2023
SELL
$17.0 - $25.43 $374,204 - $559,765
-22,012 Reduced 59.54%
14,959 $290,000
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $271,402 - $857,378
35,385 Added 2231.08%
36,971 $772,000
Q2 2022

Aug 11, 2022
SELL
$4.11 - $8.75 $58,234 - $123,978
-14,169 Reduced 89.93%
1,586 $13,000
Q1 2022

May 11, 2022
SELL
$7.01 - $14.1 $266,947 - $536,942
-38,081 Reduced 70.74%
15,755 $110,000
Q4 2021

Feb 10, 2022
BUY
$12.27 - $18.26 $457,278 - $680,513
37,268 Added 224.94%
53,836 $727,000
Q3 2021

Nov 12, 2021
BUY
$16.48 - $28.98 $273,040 - $480,140
16,568 New
16,568 $280,000

Others Institutions Holding PLRX

# of Institutions
127
Shares Held
57.7M
Call Options Held
245K
Put Options Held
86.7K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $72M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email